WDG
ABBV icon

Wealth Dimensions Group’s AbbVie ABBV Stock Holding History

Wealth Dimensions Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Sell
5,070
-51
-1% -$11K 0.23% 55
2026
Q1 		$1.11M Sell
5,121
-106
-2% -$23.5K 0.22% 57
2025
Q4 		$1.19M Sell
5,227
-427
-8% -$97.3K 0.24% 55
2025
Q3 		$1.31M Sell
5,654
-86
-1% -$17.5K 0.27% 49
2025
Q2 		$1.07M Buy
5,740
+36
+0.6% +$6.69K 0.23% 57
2025
Q1 		$1.2M Sell
5,704
-34
-0.6% -$6.61K 0.29% 45
2024
Q4 		$1.02M Buy
5,738
+1,125
+24% +$207K 0.25% 52
2024
Q3 		$911K Sell
4,613
-32
-0.7% -$5.97K 0.23% 50
2024
Q2 		$797K Buy
4,645
+120
+3% +$19.9K 0.23% 55
2024
Q1 		$824K Buy
4,525
+59
+1% +$10.2K 0.24% 51
2023
Q4 		$692K Buy
4,466
+144
+3% +$21K 0.22% 57
2023
Q3 		$644K Buy
4,322
+94
+2% +$13.8K 0.23% 57
2023
Q2 		$570K Buy
4,228
+119
+3% +$17.4K 0.21% 69
2023
Q1 		$655K Sell
4,109
-197
-5% -$30.1K 0.25% 55
2022
Q4 		$696K Buy
4,306
+100
+2% +$15.3K 0.28% 50
2022
Q3 		$565K Sell
4,206
-40
-0.9% -$5.74K 0.28% 49
2022
Q2 		$650K Sell
4,246
-104
-2% -$15.9K 0.31% 49
2022
Q1 		$705K Sell
4,350
-108
-2% -$15.7K 0.33% 51
2021
Q4 		$604K Sell
4,458
-41
-0.9% -$4.84K 0.3% 61
2021
Q3 		$485K Buy
4,499
+99
+2% +$11.3K 0.31% 68
2021
Q2 		$496K Sell
4,400
-282
-6% -$31.8K 0.34% 64
2021
Q1 		$507K Sell
4,682
-65
-1% -$6.95K 0.39% 57
2020
Q4 		$509K Buy
+4,747
New +$456K 0.44% 46

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wealth Dimensions Group's ABBV Position: Q2 2026 in Review

Wealth Dimensions Group reduced its AbbVie (ABBV) stake by 1% in Q2 2026, selling an estimated $11K and leaving 5,070 shares worth $1.28M. The position accounts for 0.23% of the portfolio, ranked #55.

Wealth Dimensions Group first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.31M in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wealth Dimensions Group held 5,070 shares of AbbVie worth $1.28M as of Q2 2026.
  • Wealth Dimensions Group sold 51 AbbVie shares in Q2 2026, an estimated $11K.
  • AbbVie made up 0.23% of Wealth Dimensions Group's portfolio in Q2 2026, its #55 holding.
  • Wealth Dimensions Group first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • Wealth Dimensions Group's AbbVie position peaked at $1.31M in Q3 2025.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wealth Dimensions Group's 13F filing for Q2 2026, filed 22 Jul 2026.